Advertisement

Internet Resources on Antimicrobial Resistance

  • Matthew E. Falagas
  • Efthymia A. Karveli
Part of the Infectious Disease book series (ID)

Our lists of WWW resources of data from surveillance studies on antimicrobial resistance may be useful to practitioners, especially infectious disease specialists, as well as to scientists with a research interest in the fi eld of antimicrobial resistance. Such educational and informative WWW resources are potentially helpful because of the growing problem of antimicrobial resistance that has become a significant public health concern worldwide (2). This refers practically to all types of pathogens, including viruses, bacteria, mycobacteria, fungi, and parasites. Previous studies have shown the impact of antimicrobial resistance on various outcomes including mortality, morbidity, and cost and length of hospitalization (3–5).

Keywords

Antimicrobial Resistance Methicillin Resistant Staphylococcus Aureus Antimicrobial Chemotherapy Interactive Database Infectious Disease Specialist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Falagas ME, Karveli EA. World Wide Web resources on antimicrobial resistance. Clin Infect Dis 2006; 43(5):630–633PubMedCrossRefGoogle Scholar
  2. 2.
    Zhang R, Eggleston K, Rotimi V, et al. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2006; 2:6PubMedCrossRefGoogle Scholar
  3. 3.
    Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006; 10(2):R48PubMedCrossRefGoogle Scholar
  4. 4.
    Ang JY, Ezike E, Asmar BI. Antibacterial resistance. Indian J Pediatr 2004; 71:229–239PubMedCrossRefGoogle Scholar
  5. 5.
    Myrianthefs PM, Kalafati M, Samara I, et al. Nosocomial pneumonia. Crit Care Nurs Q 2004; 27:241–257PubMedGoogle Scholar
  6. 6.
    Struelens MJ, Van Eldere J. Conclusion: ESCMID declaration on meeting the challenges in clinical microbiology and infectious diseases. Clin Microbiol Infect 2005; 11 Suppl 1:50–51PubMedCrossRefGoogle Scholar
  7. 7.
    Talbot GH, Bradley J, Edwards JE, et al. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. CID 2006; 42:657–668CrossRefGoogle Scholar
  8. 8.
    Styers D, Sheehan DJ, Hogan P, et al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006; 5:2PubMedCrossRefGoogle Scholar
  9. 9.
    Johnson DM, Stilwell MG, Fritsche TR, et al. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999–2003). Diagn Microbiol Infect Dis 2006; 56:69–74PubMedCrossRefGoogle Scholar
  10. 10.
    Hoffman-Roberts HL, C Babcock E, Mitropoulos IF. Investigational new drugs for the treatment of resistant pneumococcal infections. Expert Opin Investig Drugs 2005; 14:973–995PubMedCrossRefGoogle Scholar
  11. 11.
    Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol 2005; 8:518–524PubMedCrossRefGoogle Scholar
  12. 12.
    Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect 2005; 11 Suppl 5:4–16PubMedCrossRefGoogle Scholar
  13. 13.
    Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA; EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355(7):666–674PubMedCrossRefGoogle Scholar
  14. 14.
    Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 2007; 13(2):117–119PubMedCrossRefGoogle Scholar
  15. 15.
    Woodall JP. Global surveillance of emerging diseases: the ProMED-mail perspective. Cad Saude Publica 2001; 17 Suppl: 147–154PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Matthew E. Falagas
    • 1
  • Efthymia A. Karveli
    • 2
  1. 1.Alfa Institute of Biomedical Sciences (AIBS)MarousiGreece
  2. 2.Alfa Institute of Biomedical Sciences (AIBS)AthensGreece

Personalised recommendations